Pfizer Stock’s Window Is Closed — Even With the COVID-19 Vaccine Posted by Charles Sizemore | Jan 25, 2021 | Investing Pfizer’s stock has done well, thanks to its COVID-19 vaccine. But our Green Zone Ratings system is a bit more bearish on the stock now. Read More
Time Is Your No. 1 Asset When You Invest Posted by Charles Sizemore | Dec 5, 2020 | Personal Finance When it comes to investing, time is your greatest asset. Here’s one of the most important lessons you can pass on to younger generations. Read More
How to Know You’ll Pay the Right Price for High-Growth Stocks Posted by Adam O'Dell | Nov 16, 2020 | Investing Don’t let Wall Street tell you that you must choose between “cheap” value stocks and “expensive” high-growth stocks. How to get both… Read More
Momentum: The Key to Gains Over 100% Posted by Coty Poynter | Nov 12, 2020 | Investing The Money & Markets team is all about using momentum to “buy high … sell higher” in the stock market because it leads to outsized gains. Read More
The Quality Factor: Find Stocks That Weather the Worst Markets Posted by Adam O'Dell | Nov 9, 2020 | Investing The quality factor of Green Zone Ratings helps you determine if a company’s stock has the profits to back up its valuation. Read More